Answer
The safety and efficacy of glofitamab (Columvi) in children under 18 have not been established, and no data are available.
Sources for this answer
- Columvi 2.5 mg, 10 mg concentrate for solution for infusionRoche Products Limited · emc · SmPC §4.2 Posology and method of administration · Version 6Document updated
Sources checked